AMA votes no on Medicare for all

As Medicare for all continues to gain traction among American voters and more Democratic presidential nominees take up the platform, the American Medical Association has decided not to support such an initiative.

The group, which represents physicians, voted on its new policies and leadership during its annual meeting in Chicago at the beginning of June. Instead of adopting Medicare for all, which provides universal healthcare through a single payer, the AMA opted to pursue policies that strengthen the Affordable Care Act.

During the meeting, the AMA’s House of Delegates––­­its policymaking body—voted 53% to 47% against a measure that would have dropped a decades-long opposition to a single-payer system, The Hill reported.

The AMA reaffirmed its commitment to the ACA during the meeting, citing new recommendations that recognize the healthcare law is “not broken, but it is imperfect.” The association’s goal with the ACA is to improve access to health insurance coverage to the uninsured. That includes expanding the amount of and eligibility for premium tax credits, removing the subsidy cliff, increasing cost-sharing reductions received by those who are qualified, and extending eligibility for cost-sharing reductions beyond 250% of the family poverty level.

“Since the ACA was enacted into law in 2010, millions of Americans have gained health insurance,” AMA President Barbara L. McAneny, MD, said in a statement. “The policy question now is how to improve the law to insure even more. We need policies to make coverage more affordable for millions of Americans­­––both in the premiums they pay, as well as their cost-sharing responsibilities.” 

In addition to voting on healthcare policies that aim to expand coverage, the AMA elected its future leadership and swore in its new president.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup